Ezetimibe-Loaded Nanostructured Lipid Carrier Based Formulation Ameliorates Hyperlipidaemia in an Experimental Model of High Fat Diet

Ezetimibe (EZE) possesses low aqueous solubility and poor bioavailability and in addition, its extensive hepatic metabolism supports the notion of developing a novel carrier system for EZE. Ezetimibe was encapsulated into nanostructured lipid carriers (EZE-NLCs) via a high pressure homogenization te...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Molecules
Päätekijät: Agrawal, Yogeeta O., Mahajan, Umesh B., Agnihotri, Vinit V., Nilange, Mayur S., Mahajan, Hitendra S., Sharma, Charu, Ojha, Shreesh, Patil, Chandragouda R., Goyal, Sameer N.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: MDPI 2021
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7967240/
https://ncbi.nlm.nih.gov/pubmed/33803259
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/molecules26051485
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia